Skye Hodson, PhD
Vice President, Clinical Solutions
View profile
Vice President, Clinical Solutions
Citeline
Skye is a Biochemist with over 10 years of life sciences CRO and CCO experience, delivering tangible business outcomes across strategy, product development, clinical operations, commercialization and growth. He focuses on leveraging enabling technologies to accelerate the development of new medicines, having seen firsthand how data-driven insights and advanced analytics/AI can unlock real value for patients and companies. He is passionate about disrupting the status quo and advancing holistic health agendas, engaging with the community as a speaker, mentor and advocate for innovation in life sciences.
Skye is a Biochemist with over 10 years of life sciences CRO and CCO experience, delivering tangible business outcomes across strategy, product development, clinical operations, commercialization and growth. He focuses on leveraging enabling technologies to accelerate the development of new medicines, having seen firsthand how data-driven insights and advanced analytics/AI can unlock real value for patients and companies. He is passionate about disrupting the status quo and advancing holistic health agendas, engaging with the community as a speaker, mentor and advocate for innovation in life sciences.
Ritupriya Yamujala
VP Solution Consulting
View profile
VP Solution Consulting
Norstella
Ritupriya holds a Master of Business and Science in Biotechnology and Genomics, with over a decade of experience in Life Sciences market intelligence, business development, and go-to-market strategy. She has worked with a wide range of large and mid-sized pharmaceutical companies, biotechs, service providers to the pharmaceutical industry, and financial and consulting firms, providing strategic insights on key business questions across multiple phases of pipeline development. With a deep, firsthand understanding of the hurdles that pharma companies face in bringing critical therapies to market, she is excited about the evolving use of AI in life sciences and pharma as an enabler of faster results and an enhancer of complex workflows.
Ritupriya holds a Master of Business and Science in Biotechnology and Genomics, with over a decade of experience in Life Sciences market intelligence, business development, and go-to-market strategy. She has worked with a wide range of large and mid-sized pharmaceutical companies, biotechs, service providers to the pharmaceutical industry, and financial and consulting firms, providing strategic insights on key business questions across multiple phases of pipeline development. With a deep, firsthand understanding of the hurdles that pharma companies face in bringing critical therapies to market, she is excited about the evolving use of AI in life sciences and pharma as an enabler of faster results and an enhancer of complex workflows.
